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E-mail address: ecarrizo@mail.fcq.unc.edu.ar (M.EThe X-ray structure of rabbit glycogenin containing the T82M (T83M according to previous authors
amino acid numbering [1]) mutation causing glycogenosis showed the loss of Thr82 hydrogen bond
to Asp162, the residue involved in the activation step of the glucose transfer reaction mechanism.
Autoglucosylation, maltoside transglucosylation and UDP-glucose hydrolyzing activities were abol-
ished even though afﬁnity and interactions with UDP-glucose and positioning of Tyr194 acceptor
were conserved. Substitution of Thr82 for serine but not for valine restored the maximum extent
of autoglucosylation as well as transglucosylation and UDP-glucose hydrolysis rate. Results provided
evidence sustaining the essential role of the lost single hydrogen bond for UDP-glucose activation
leading to glycogenin-bound glycogen primer synthesis.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Glycogenin is the name given [2] to the protein moiety of pro-
tein bound glycogen [2,3], which initiates the glucose polymeriza-
tion by autoglucosylation from UDP-glucose and Mn2+, forming the
glycogen synthase substrate for further glucopolymerization [4,5].
The produced maltooligosaccharide, linked to Tyr194 [6] is re-
quired to prime the de novo biosynthesis of glycogen [1,7]. Glycog-
enin-1 is one of the human glycogenin isoforms which is mainly
expressed in muscle [8]. Its amino acid sequence is highly homol-
ogous to the sequence of the rabbit muscle enzyme, the most stud-
ied member of this protein family displaying a 93% identity. A
metabolic disorder associated with glycogen depletion caused by
compound heterozygosity for a non-sense and a missense muta-
tion in the human glycogenin-1 gene GYG1, has been recently de-
scribed [1]. The missense mutation results in the expression ofchemical Societies. Published by E
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. Carrizo).inactive T82M glycogenin mutant which causes deﬁcient priming
of glycogen synthesis. The X-ray structure of partially glucosylated
rabbit muscle glycogenin containing bound UDP-glucose and Mn2+
and of rabbit glycogenin species in which Asp162 was substituted
by either serine or asparagine has been solved [9,10]. The muta-
tions provided evidence for the essential role of Asp162 in the
retaining mechanism of glycogenin autoglucosylation. This would
involve the glucosyl-Asp162 intermediate formation or oxocarbe-
nium intermediate stabilization facilitating the UDP-glucose car-
bon phosphoryl bond breakage [10]. Thr82 is not only present in
human and rabbit glycogenin, but is also conserved in many mem-
bers of this protein family [11]. Thus, it was of interest to introduce
the T82M mutation into the well-studied rabbit muscle glycogenin
in order to analyze the cause of the inhibition to prime glycogen
synthesis.
In the present work, non-glucosylated recombinant rabbit
muscle glycogenin species truncated at residue 270 were used.
The X-ray crystal structures of the T82M-D270 mutant and of
the non-glucosylated wild type apo-D270 species has been
solved. Besides autoglucosylation, DBM transglucosylation and
UDP-glucose hydrolytic activities has been determined for
T82M-D270 and for mutants in which Ser and Val replaced
Thr82, in order to ascertain whether the mutation prevented
the UDP-glucose activation by Asp162 or the ultimate glucose
transfer to Tyr194.lsevier B.V. All rights reserved.
1 Atomic coordinates and structure factors have been deposited in the Protein Data
Bank as entries 3V8Y, 3V8Z, 3V90 and 3V91, for apo-D270, apo-D270 complexed with
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2.1. Materials
The Escherichia coli strain CGSC 4997, a galactose-minus strain
lacking UDP-glucose pyrophosphorylase activity, was obtained
from the E. coli Genetic Stock Center, Department of Molecular, Cel-
lular, and Developmental Biology, Yale University. UDP-[14C]glu-
cose (320 mCi/mmol) was purchased from Fundación Instituto
Leloir (Buenos Aires, Argentina). Except where indicated, all other
reagents came from Sigma.
2.2. Mutagenesis, expression and puriﬁcation
The non-glucosylated wild type glycogenin truncated at residue
270, apo-D270, was obtained in the E. coli strain CGSC 4997, as pre-
viously described [12]. The plasmid containing the inserted cDNA
corresponding to the ﬁrst 270 amino acids was used as a template
to generate the T82M-D270, T82S-D270 and T82V-D270 mutants
by site-directed mutagenesis with the QuickChange kit (Strata-
gene). The mutant plasmids were also transformed into the
E. coli strain CGSC 4997 and the proteins were expressed and puri-
ﬁed as described for the apo-D270 species.
2.3. Activity assays
For the speciﬁc autoglucosylation rate (SAR) measurement,
4 lM of the indicated glycogenin species was incubated in a ﬁnal
volume of 10 ll with 80 lM UDP-[14C] glucose, 0.1 M MES pH 7.0
and 5 mM MnSO4, for 2 min at 30 C, and the incubated mixture
was processed and counted as previously described [12]. For
UDP-glucose hydrolysis determination, 2 ll aliquots of the same
incubation mixture were subjected to HPTLC and the released
[14C]glucose was scraped from the plate and counted as elsewhere
indicated [12]. For the maximum speciﬁc autoglucosylation extent
(MSAE) determination, 320 lMUDP-[14C]glucose was used and the
incubation time was 60 min. For the transglucosylation assay, the
incubation system used for MSAE determination was supple-
mented with 0.2 mM DBM and measurement carried out as previ-
ously indicated [13].
2.4. Crystallization, data collection and structure determination
Apo-D270 was crystallized in 1 M ammonium sulfate and 0.1 M
sodium phosphate pH 6.7, and T82M-D270 mutant in 12% (w/v)
PEGMME 5000, 0.1 M MES pH 6.5 and 0.2 M ammonium sulfate,
as previously described [9,10]. The crystals were grown using the
hanging drop vapor diffusion method at 4 C. To prepare the com-
plexes with ligands, the crystals were soaked in mother liquor con-
taining 1 mM MnSO4 and 1 mM UDP or UDP-glucose. All crystals
were cryo-protected by soaking in a solution containing 70%
mother liquor and 30% glycerol before being ﬂash-frozen. Data
were collected at the Protein Crystallography Beamline D03B-
MX1 of the Laboratório Nacional de Luz Síncrotron (LNLS), Campi-
nas, Brazil (wavelength = 1.430 Å), at 100 K using a Mar CCD detec-
tor (Mar Research). The data were processed and scaled using
MOSFLM [14] and Scala [15], and subsequent analysis was per-
formed by using the CCP4 suite [16]. The crystals of apo-D270
and T82M-D270 and the complexes with ligands were isomor-
phous with the glucosylated wild type glycogenin crystal [9, PDB
entry 1LL3]. Thus, this structure without solvent molecules was
used as a starting model for the reﬁnement of the data, using the
program REFMAC5 [17]. After the proper side chains had been
introduced, the models were subjected to alternating cycles of
reﬁnement in REFMAC5 and manual inspection and model build-ing with the program Coot [18]. Ligand and solvent molecules were
added to the models in the ﬁnal stages of reﬁnement based on
examination of difference density maps.
3. Results and discussion
3.1. Crystal structures
In order to search for a glycogenin conformational modiﬁcation
as a consequence of the substitution of Thr82 by Met, the X-ray
structures of apo-D270 and T82M-D270, and of these species com-
plexed with UDP/Mn2+ and UDP-glucose/Mn2+, respectively, were
solved to resolutions between 2.20 and 2.00 Å (Supplementary Ta-
ble 1)1. As for D162S and D159N mutants [10], the crystals belonged
to the orthorhombic I222 space group with similar cell dimensions,
one monomer per asymmetric unit, and the biological dimer being
generated by a crystallographic twofold axis.
The structure of the wild type non-glucosylated apo-D270 spe-
cies was very similar to that of the described glucosylated enzyme
structure [9, PDB entry 1LL3], with an r.m.s.d. of 0.51 Å for the C-a
atoms. The most signiﬁcant difference was a shift in the position of
the helix containing the Tyr194 residue. Tyr194 was found to be
positioned with the hydroxyl group pointing to the sugar donor
binding site within the same dimer subunit in the non-glucosylat-
ed glycogenin, whereas in the glucosylated species, the glucosylat-
ed Tyr194 side chain pointed toward the protein outside
(Supplementary Fig. 1A). Attempts to obtain crystals of apo-D270
with UDP-glucose failed because they dissolved after a few min-
utes of soaking with UDP-glucose/Mn2+, a behavior not observed
when the soaking was carried out with UDP/Mn2+, which allowed
us to solve the structure of the complex. By superimposing the
structures of apo-D270 complexed with UDP/Mn2+ and glucosylat-
ed glycogenin complexed with UDP-glucose/Mn2+ [9, PDB entry
1LL2], we determined that the distance between the Tyr194 hydro-
xyl group and the phosphorus atom of UDP b-phosphate in apo-
D270 was 12.0 Å within the same dimer subunit and 20.4 Å in
opposing dimer subunits (Supplementary Fig. 1B). For the glucosy-
lated protein these distances were 20.1 Å and 15.1 Å in the same
and opposing subunits, respectively. Such a distance modiﬁcation
might be produced by glucosylation, as it has been proposed before
for the non-glucosylated D159S and D162N mutants [10].
The structures of the T82M-D270 mutant and the glucosylated
wild type enzyme, both complexed with UDP-glucose/Mn2+,
showed the same contacts with UDP (Fig. 1) and similar distances
separating the phosphorus atom of UDP-glucose b-phosphate and
the Tyr194 hydroxyl group. Also similar interactions were ob-
served between the C6 hydroxyl group of glucose forming hydro-
gen bonds with Ser133 and Asp101, and the C4 equatorial
hydroxyl group with Asn132 and Gln163, responsible for the hex-
ose C4 epimer speciﬁcity of the enzyme (Fig. 1). This indicated that
the T82M mutation did not modify the binding contacts of the en-
zyme to the donor substrate. Furthermore, UDP binding afﬁnity of
T82M-D270 and apo-D270 were quite similar as revealed by Iso-
thermal Titration Calorimetry (results not shown). Besides, the po-
sition and distance of 6.1 Å separating the carboxylate of Asp162
and the carbon-phosphoryl bond of UDP-glucose was unchanged.
Replacement by the bulkier hydrophobic side chain of methionine
had little effect on the overall structure (r.m.s.d. value for C-a
atoms 0.44 Å) (Fig. 2A), with only a slight movement of the region
between residues 73 and 79. However, hydrophobic contacts with
Leu79, Val81, Leu83, Ala152, Gly161 and Leu165 might be favored.UDP, T82M-D270 and T82M-D270 complexed with UDP-glucose, respectively.
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the electron density maps of T82M-D270 (Fig. 2B). The Thr82 hy-
droxyl group was located at 2.90 Å of the main chain amide nitro-
gen of Asp162 as to allow hydrogen bonding (Fig. 2C). Substitution
of Thr82 with methionine did not appear to either sterically inter-
fere with the position of the surrounding amino acid side chains or
to break the network of contacts that these residues could make,
with the only exception being the loss of the hydrogen bond be-
tween Thr82 and Asp162.
3.2. Effect of Thr82 substitution on glycogenin activity
As it has been mentioned the substitution of Thr82 by methi-
onine led to the loss of the glycogenin capacity to prime glycogen
synthesis. However, neither the effect on maltoside transglucosy-
lation and UDP-glucose hydrolyzing activities nor the degree ofFig. 1. Comparison of T82M-D270 and glucosylated wild-type glycogenin structures. Ste
of glucosylated wild-type glycogenin (orange) bound to UDP-glucose/Mn2+, showing the
superimposed with the program LSQKAB [19], and the ﬁgure was prepared using the prog
the reader is referred to the web version of this article.)
Fig. 2. Comparison of T82M-D270 and apo-D270 structures. (A) Superposition of apo-D
residues in position 82 and Asp162 as ball-and-stick representation. Electron density of t
apo-D270 (C). The structures were superimposed and the ﬁgure was prepared as indica
reader is referred to the web version of this article.)
Table 1
Glucosyl transfer activities of wild type non-glucosylated and mutant glycogenin enzyme
Glycogenin species Autoglucosylation DBM tra
MSAE (pmol/pmol) SAR (pmol/min/pmol)
Apo-D270 11.45 ± 0.11 0.86 ± 0.02 9.42 ± 0.4
T82M-D270 <0.05 <0.05 <0.05
T82S-D270 10.60 ± 0.06 0.57 ± 0.01 8.87 ± 1.0
T82V-D270 0.57 ± 0.01 <0.05 <0.05
Values are the the means ± SD of triplicate determinations.autoglucosylation inhibition produced by the mutation was
determined [1]. Based on the observed loss of Thr82 hydrogen
bond to Asp162, it was of interest to analyze the effect on glyc-
ogenin activity of threonine replacement by amino acids with or
without hydroxyl containing side chain. We thus analyzed the
capacity to carry out the three mentioned glucose transfer reac-
tions of T82M-D270 and of species in which Thr82 was replaced
by Ser or Val. For autoglucosylation, both, the speciﬁc autoglu-
cosylation rate (SAR) and maximum speciﬁc autoglucosylation
extent (MSAE) were determined. As shown in Table 1, replace-
ment of Thr82 by Met or Val but not by Ser produced complete
inactivation of the three transfer reactions. Substitution by Ser
resulted in no modiﬁed rate of DBM transglucosylation and
UDP-glucose hydrolysis and the MSAE capacity was unaffected
even though the autoglucosylation rate was diminished by one
third.reoview of the superposition of T82M-D270 (green) and the described structure [9]
residues involved in the protein–sugar nucleotide interactions. The structures were
ram CCP4mg [20]. (For interpretation of the references to color in this ﬁgure legend,
270 (purple) and T82M-D270 (green) crystal structures. The boxed area shows the
he 2Fobs – Fc maps contoured at 1 r for residues 82 and 162 in T82M-D270 (B) and
ted in Fig. 1. (For interpretation of the references to color in this ﬁgure legend, the
s.
nsglucosylation (pmol/min/pmol) UDP-glucose hydrolysis (pmol/min/pmol)
9 1.27 ± 0.03
<0.05
5 0.96 ± 0.05
<0.05
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ogenin of the mutation causing glycogenosis produced, besides
complete autoglucosylation inhibition, the loss of transglucosyla-
tion and UDP-glucose hydrolyzing activities. It is to be noticed that
the possibility of the mutation only preventing the ultimate glu-
cose transfer to Tyr194, due to alteration of the acceptor residue
accessibility, should result in abolished autoglucosylation but nor-
mal DBM transglucosylation and UDP-glucose hydrolysis activities.
Strikingly, inactivation occurred without changes of Tyr194 posi-
tioning, UDP-glucose interaction contacts and UDP binding afﬁnity
but with loss of Thr82 hydrogen bonding to Asp162. Thus, the lack
of glucose transfer activity was not due, at least exclusively, to the
accessibility of the Tyr194 acceptor. The MSAE capacity and the
rate of transglucosylation and UDP-glucose hydrolysis were re-
tained when the Thr82 substitute side chain lacked the methyl
but conserved the hydroxyl group of threonine as in serine. On
the contrary, activity was completely lost when the threonine hy-
droxyl was absent as in valine. Our work provides structural and
biochemical evidences in support of the essential role of Thr82
for glycogenin activity by hydrogen bonding to Asp162. This en-
sure the nucleophilic carboxylate attack to the UDP-glucose car-
bon-phosphoryl bond for formation of glucosyl-Asp162
intermediate or stabilization of oxocarbenium involved in the glu-
cose transfer to Tyr194, DBM or water.
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